Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Oncology Research and Treatment

35, No. 12, 2012

Issue release date: December 2012

Published under Onkologie
Add all to MyReading List
FREE ONLINE ACCESS
Editorial Board
721

Editorial Board

Onkologie 2012;35:721 (DOI:10.1159/000236228)
Free Access
Contents · Inhalt
722

Vol. 35, Issue 12, December 2012 / Band 35, Heft 12, Dezember 2012

Onkologie 2012;35:722-724 (DOI:10.1159/000170922)
Free Access
Editorial
728

Professor Hans-Joachim Schmoll – 10 Years Editor-in-Chief of Onkologie

Hallek M.
Onkologie 2012;35:728 (DOI:10.1159/000345824)
Free Access
Further Section · Weitere Sektionen
730

Acknowledgement to Reviewers

Onkologie 2012;35:730–732 (DOI:10.1159/000188060)
Free Access
Original Article · Originalarbeit
733

Prognostic Significance of Bcl-2, Tumor-Associated Macrophages, and Total Neoplastic and Inflammatory Lymph Node Involvement in Advanced Stage Classical Hodgkin’s Lymphoma

Jakovic L.R. · Mihaljevic B.S. · Jovanovic M.D.P. · Bogdanovic A.D. · Andjelic B.M. · Bumbasirevic V.Z.
Onkologie 2012;35:733–739 (DOI:10.1159/000343664)
Free Access
740

Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience

Cetin B. · Benekli M. · Oksuzoglu B. · Koral L. · Ulas A. · Dane F. · Turker I. · Kaplan M.A. · Koca D. · Boruban C. · Yilmaz B. · Sevinc A. · Berk V. · Isıkdogan A. · Uncu D. · Harputluoglu H. · Coskun U. · Buyukberber S.
Onkologie 2012;35:740–745 (DOI:10.1159/000345040)
Free Access
747

Prognosis in Patients with Non-Small Cell Lung Cancer Who Received Erlotinib Treatment and Subsequent Dose Reduction due to Skin Rash

Takashima N. · Kimura T. · Watanabe N. · Umemura T. · Katsuno S. · Arakawa K. · Fukatsu M. · Nakamura N. · Nishiyama O. · Kataoka K. · Kondoh Y. · Taniguchi H.
Onkologie 2012;35:747–752 (DOI:10.1159/000345039)
Free Access
755

Biliary Tract Cancer: A Survey Regarding the Current Oncological Daily Care Practice in Germany

Sinn M. · Bischoff S. · Nehls O. · Pelzer U. · von Weizsäcker F. · Kubicka S. · Stieler J.M. · Caca K. · Riess H.
Onkologie 2012;35:755–760 (DOI:10.1159/000345115)
Free Access
763

Delta-Like Ligand 4 Correlates with Endothelial Proliferation and Vessel Maturation in Human Malignant Glioma

Li Z.-Q. · Gong L.-L. · Wen Z.-H. · Wang J. · Xu C.-S. · Huang X.-D.
Onkologie 2012;35:763–768 (DOI:10.1159/000345116)
Free Access
770

Could a Possible Crosstalk between AMPK and TGF-β Signaling Pathways Be a Key Player in Benign and Malignant Salivary Gland Tumors?

Ghahhari N.M. · Ghahhari H.M. · Kadivar M.
Onkologie 2012;35:770–774 (DOI:10.1159/000345131)
Free Access
Case Report · Kasuistik
776

HER2 Blockade in Metastatic Collecting Duct Carcinoma (CDC) of the Kidney: A Case Report

Bronchud M.H. · Castillo S. · Escriva de Romaní S. · Mourelo S. · Fernández A. · Baena C. · Murillo J. · Julia J.C. · Esquius J. · Romero R. · Andreu X.
Onkologie 2012;35:776–779 (DOI:10.1159/000345041)
Free Access
780

Biliary Obstruction Induces Extremely Elevated Serum CA 19-9 Levels: Case Report

Onal C. · Colakoglu T. · Ulusan S.N. · Yapar A.F. · Kayaselcuk F.
Onkologie 2012;35:780–782 (DOI:10.1159/000345110)
Free Access
783

Toxic Epidermal Necrolysis after Pemetrexed and Cisplatin for Non-Small Cell Lung Cancer in a Patient with Sharp Syndrome

Then C. · von Einem J.C. · Müller D. · Flaig M.J. · Huber R.M. · Reincke M.
Onkologie 2012;35:783–786 (DOI:10.1159/000345109)
Free Access
Further Section · Weitere Sektionen
787

Imprint

Onkologie 2012;35:787 (DOI:10.1159/000178575)
Free Access
788

Mitteilungen onkologischer Gesellschaften · Reports of Oncological Societies

Onkologie 2012;35:788–790 (DOI:10.1159/000170963)
Free Access
791

PharmaForum

Onkologie 2012;35:791-793 (DOI:10.1159/000233224)
Free Access
794

PharmaForum

Onkologie 2012;35:794-795 (DOI:10.1159/000312570)
Free Access
796

PharmaNews / PharmaTicker

Onkologie 2012;35:796-800 (DOI:10.1159/000190054)
Free Access
801

Meetings and Conferences · Tagungen und Kongresse

Onkologie 2012;35:801-802 (DOI:10.1159/000258180)
Free Access
803

Contents Vol. 35, 2012

Onkologie 2012;35:803-808 (DOI:10.1159/000242452)
Free Access
809

Inhalt Band 35, 2012

Onkologie 2012;35:809-814 (DOI:10.1159/000259400)
Free Access
815

Guidelines for Authors

Onkologie 2012;35:815 (DOI:10.1159/000170964)
Free Access
816

Contents of Forthcoming Issues · Themenvorschau

Onkologie 2012;35:816 (DOI:10.1159/000325292)
Free Access